AS

Anthati Sai Latha Sree

Active Director Managing Director DIN 10775938
DIN 10775938 First appointment Sep 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Anthati Sai Latha Sree

Data last updated:

Anthati Sai Latha Sree is a Managing Director at Anvistar Pharmaceutical Private Limited (since 2024). The company operates in Paper.

DIN 10775938
Primary Designation Managing Director
Industry Paper
First Appointment 12 Sep 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director12 Sep 20242024Active

Board colleagues of Anthati Sai Latha Sree

NameDINCompanyDesignation
Bhoomi Mogudala10775939Anvistar Pharmaceutical Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Anvistar Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Anthati Sai Latha Sree

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anthati Sai Latha Sree

Anthati Sai Latha Sree currently holds 1 directorship: Anvistar Pharmaceutical Private Limited (Managing Director, since 12 Sep 2024).

Anthati Sai Latha Sree was first appointed on 12 Sep 2024 as Managing Director at Anvistar Pharmaceutical Private Limited.

The current boards of Anthati Sai Latha Sree's companies include Bhoomi Mogudala (Anvistar Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available